ADA Guideline Advises Against Light-Based Adjuncts for Oral Cancer Detection

Posted: June 5, 2026

ADA Guideline Advises Against Light-Based Adjuncts for Oral Cancer Detection

Edited by Dentaltown staff

The American Dental Association’s living guideline on early oral cancer detection has been updated to advise against using light-based adjunct devices to determine whether a patient needs a biopsy, citing high rates of false-positive results.

In recommendations published online June 2 in The Journal of the American Dental Association, the guideline panel suggests against relying on light-based devices — which include autofluorescence and tissue-reflectance instruments — to decide whether an oral lesion warrants a biopsy or referral. The recommendation rests on a companion systematic review that found the devices generate frequent false positives and only low-certainty evidence overall.

The systematic review pooled data from 36 diagnostic accuracy studies. Pooled sensitivity ranged from 86% for autofluorescence devices to 91% for tissue-reflectance devices, which the authors considered potentially acceptable, but specificity was far weaker, at 56% and 26%, respectively. At the disease prevalence expected in everyday practice, the reviewers estimated that at least 91% of positive results would be false positives, exposing patients to unnecessary anxiety, biopsies, and costs.

The authors rated the certainty of the evidence as low to very low and noted that most studies were conducted in specialty rather than primary care settings, where the devices would most likely be used. They also found no studies evaluating light-based tests in people without visible mucosal abnormalities, leaving their value as a screening tool for asymptomatic patients unestablished.

Biopsy with histopathologic assessment remains the reference standard for diagnosing oral squamous cell carcinoma and oral potentially malignant disorders, the guideline reaffirms. The recommendations are part of the ADA Living Guideline Program, established in 2025, which updates guidance as evidence emerges and presents it through an interactive chairside format. Light-based adjuncts are the third topic in a four-part series, following cytology in March and vital staining in April; recommendations on salivary tests are expected later this year.

The living guideline is a collaboration between the ADA and the Center for Integrative Global Oral Health at the University of Pennsylvania School of Dental Medicine. The systematic review was led by Olivia Urquhart, with the companion guideline authored by Ankita Shashikant Bhosale and colleagues.

Sources:
The Journal of the American Dental Association, “Light-based adjuncts to determine the need for biopsy for early detection of oral squamous cell carcinoma and potentially malignant disorders: An evidence summary of a living systematic review, Version 2026 1.0,” by Olivia Urquhart et al. (DOI 10.1016/j.adaj.2026.03.028): jada.ada.org/article/S0002-8177(26)00238-2
The Journal of the American Dental Association, “Living evidence-informed guideline on the early detection of oral squamous cell carcinoma and potentially malignant disorders: Light-based adjuncts to determine the need for biopsy, Version 2026 1.0,” by Ankita Shashikant Bhosale et al., published online June 2, 2026 (DOI 10.1016/j.adaj.2026.04.010): doi.org/10.1016/j.adaj.2026.04.010


ADA Guideline Advises Against Light-Based Adjuncts for Oral Cancer Detection

Views: 13
Sponsors
Townie Perks
Townie® Poll
What’s actually driving most of your new patient flow right now?
  
The Dentaltown Team, Farran Media Support
Phone: +1-480-445-9710
Email: support@dentaltown.com
©2026 Dentaltown, a division of Farran Media • All Rights Reserved
9633 S. 48th Street Suite 200 • Phoenix, AZ 85044 • Phone:+1-480-598-0001 • Fax:+1-480-598-3450